Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics

NCT01503892 is registered in ClinicalTrials.gov with St. Luke's Hospital and Health Network, Pennsylvania as lead sponsor.

NCT NCT01503892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01503892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics
Lead sponsor
St. Luke's Hospital and Health Network, Pennsylvania
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2011
Completion date
Not reported
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, peripheral neuropathy